[Current advances in molecular targeted therapy of primary hepatocellular carcinoma]

Zhonghua Gan Zang Bing Za Zhi. 2009 Jun;17(6):475-7.

[Article in Chinese]

Authors

Lei Yu¹, Zhi Dai, Jian Zhou, Jia Fan

Affiliation

¹ Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

PMID: 19567036

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Benzenesulfonates / therapeutic use
Carcinoma, Hepatocellular / drug therapy*
Carcinoma, Hepatocellular / pathology
Cell Adhesion / drug effects
Cell Proliferation / drug effects
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology
Neoplasm Metastasis / prevention & control*
Neovascularization, Pathologic*
Niacinamide / analogs & derivatives
Phenylurea Compounds
Pyridines / therapeutic use
Signal Transduction / drug effects
Sorafenib

Substances

Antineoplastic Agents
Benzenesulfonates
Phenylurea Compounds
Pyridines
Niacinamide
Sorafenib